Developing faster-to-clinic formulations
Author: Phil Morton
Publication: Contract Pharma
Topic: When standard formulation strategies fail, is there a fast path to clinic for hard-to-formulate therapeutics?
Publication type: Recombumin
"Maximizing the stability of a therapeutic protein, peptide or vaccine is not an easy task. The use of recombinant albumin has the potential to bring valuable yet initially unstable, hard-to-formulate drug candidates to market."